MyHealthChecked PLC - Cardiff-based healthcare company - Posts revenue of GBP22.3 million for 2022, up 36% from GBP16.4 million in 2021. Says the increase is due to the significant demand from top high street pharmacy retailers for Covid lateral flow tests. Pretax profit, however, falls 25% to GBP1.5 million from GBP2.0 million, as sales & marketing costs rise to GBP798,000 from GBP699,000 a year earlier. Says the rise in costs is due to the "increased investment in marketing activities associated with the new and planned product launches". Incurs an additional consideration of GBP987,000 payable on the acquisition of The Genome Store Ltd, compared to none in 2021. Looking ahead, sees steady sales in 2023, and is ready to respond to spikes in demand as the year progresses.

Chief Executive Officer Penny McCormick says: "MHC has not only established itself as a player in the wellness industry but has also achieved excellent financial results in the last two years. Our commitment to innovation, customer satisfaction, and financial stability and management has set us on a path to delivering our goal of sustained liquidity."

Current stock price: 0.99 pence each, down 5.8% on Monday morning in London

12-month change: down 53%

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.